EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy and safety of onabotulinumtoxin A in the treatment of platysma prominence: A systematic review and meta-analysis of randomized clinical trials

Ofonime Chantal Udoma-Udofa, Luiz Fábio Silva Ribeiro, Lucas Rezende de Freitas, Rodrigo Alves de Sousa, Maísa de Souza Borges, Tauãna Terra Cordeiro de Oliveira, Divya Rajan, Lucas Kreutz-Rodrigues

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2025

DOI: 10.1016/j.bjps.2025.10.014 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025. Verfasst von Ofonime Chantal Udoma-Udofa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address: chanrich2000@gmail.com. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Neuromuscular Agents, Superficial Musculoaponeurotic System. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The platysma muscle influences lower face and neck aesthetics and expression. Aging can lead to platysma prominence (PP), manifesting as visible neck bands that affect appearance and well-being. Although surgical treatments exist, they are invasive and carry notable risks. This systematic review and meta-analysis evaluated the efficacy and safety of onabotulinumtoxinA for treating PP. METHODS: We systematically searched the PubMed, Cochrane Library, and Embase databases through May 2025 for studies comparing onabotulinumtoxinA with placebo. Primary outcomes were ≥1-grade bilateral neck improvement on Participant Allergan Platysma Prominence Scale (P-APPS) and Clinician Allergan Platysma Prominence Scale (C-APPS) at days 14, 60, and 120. Secondary outcomes included patient satisfaction evaluated using the Appearance of Neck and Lower Face Questionnaire and safety indicators such as bruising, hemorrhage, post-dose swallowing or talking difficulties, and other adverse events. RESULTS: Three randomized controlled trials with 1003 intention-to-treat and 912 modified intention-to-treat patients were included. OnabotulinumtoxinA significantly improved P-APPS on days 14 (RR 3.64), 60 (RR 3.46), and 120 (RR 2.57), and C-APPS on days 14 (RR 4.03), 60 (RR 3.73), and 120 (RR 2.21), all p < 0.01. Patient satisfaction was also higher on days 14 (RR 5.71), 60 (RR 5.56), and 120 (RR 5.29), all p < 0.01. No significant differences were found in the safety outcomes between the onabotulinumtoxinA and placebo groups. CONCLUSION: OnabotulinumtoxinA provides significant and sustained improvements in aesthetic and psychosocial outcomes in patients with PP, without increased risk of adverse events. These findings support its role as a less invasive and effective alternative to surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ASkin AgingNeuromuscular AgentsSuperficial Musculoaponeurotic SystemHumansRandomized Controlled Trials as TopicPatient SatisfactionTreatment Outcome

Stichwörter der Autor:innen

Cosmetic surgeryMeta-analysisOnabotulinumtoxinAPlastic surgeryPlatysmaPlatysma prominence

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin ANeuromuscular Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address: chanrich2000@gmail.com.
  • Faculty of Medicine, Federal University of São João del-Rei, Divinópolis, Brazil. Electronic address: luizfabioribeiro415@gmail.com.
  • Faculty of Medicine, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address: lucasrezendedefreitas1@gmail.com.
  • Faculty of Medicine, Federal University of São João del-Rei, Divinópolis, Brazil. Electronic address: rodrigoalvesmn13@gmail.com.
  • Faculty of Medicine, Faculty of Minas, Belo Horizonte, Minas Gerais, Brazil. Electronic address: maisaborrges@gmail.com.
  • Faculty of Medicine, Federal University of São João del-Rei, Divinópolis, Brazil. Electronic address: tauanaterra17@gmail.com.

Zitieren

APA

Udoma-Udofa, O. C., Ribeiro, L. F. S., de Freitas, L. R., de Sousa, R. A., Borges, M. S., de Oliveira, T. T. C., Rajan, D., & Kreutz-Rodrigues, L. (2025). Efficacy and safety of onabotulinumtoxin A in the treatment of platysma prominence: A systematic review and meta-analysis of randomized clinical trials. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2025.10.014

Vancouver

Udoma-Udofa OC, Ribeiro LFS, de Freitas LR, de Sousa RA, Borges MS, de Oliveira TTC, et al. Efficacy and safety of onabotulinumtoxin A in the treatment of platysma prominence: A systematic review and meta-analysis of randomized clinical trials. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025. doi:10.1016/j.bjps.2025.10.014

BibTeX
@article{UdomaUdofa2025,
  author = {Udoma-Udofa, Ofonime Chantal and Ribeiro, Luiz Fábio Silva and de Freitas, Lucas Rezende and de Sousa, Rodrigo Alves and Borges, Maísa de Souza and de Oliveira, Tauãna Terra Cordeiro and Rajan, Divya and Kreutz-Rodrigues, Lucas},
  title = {Efficacy and safety of onabotulinumtoxin A in the treatment of platysma prominence: A systematic review and meta-analysis of randomized clinical trials},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2025},
  doi = {10.1016/j.bjps.2025.10.014}
}
Kostenlos starten →